baber/WOPTO huggingface dataset:
Patent DE-69431374-T2 (DE)
Inventor: KANEKAWA NOBUYASU
IPC: G06F17/50
Filed: 1994-10-12
Granted: 2003-04-30
Abstract: The present invention relates to a self-checking circuit and a method of its configuration. More particularly, it concerns a self-checking circuit useful for highly reliable system configuration. As for a logic circuit having error detection function that has function blocks (110,111) of feeding out a plurality of signals (430,431) at least duplexed, compares the output signals of the function blocks, and detects an error on the basis of results of the comparison, wherein the operations of the function blocks are delayed.
Patent DE-69506244-T2 (DE)
Inventor: MALAMAS MICHAEL
IPC: A61P3/08
Filed: 1995-04-13
Granted: 1999-04-29
Abstract: This invention relates to novel 2-[4-(5-substituted-1,2,4-oxadiazol-3-ylmethoxy)benzyl]-1,2,5-oxadiazolidine-3,5-diones which have demonstrated antihyperglycemic activity in diabetic (ob/ob and db/db) mice, genetic animal models of non-insulin dependent diabetes mellitus (NIDDM or Type II diabetes). These compounds are represented by Formula I below:    <IMAGE>  I  wherein R1 is C6-C10 aryl, optionally substituted by one to three substituents independently selected from C1-C6 alkyl, C1-C6 alkoxy, fluorine, chlorine, bromine, iodine, C1-C3 trifluoroalkyl or C1-C3 trifluoroalkoxy; and R2 is selected from the group consisting of hydrogen, C1-C6 alkyl, fluorine, chlorine, bromine, iodine, C1-C6 alkoxy, C1-C3 trifluoroalkyl, and C1-C3 trifluoroalkoxy, or a pharmaceutically acceptable salt thereof.
Patent DE-69515067-T2 (DE)
Inventor: SPINNER BERNARD
IPC: F25D9/00
Filed: 1995-10-06
Granted: 2002-03-14
Abstract: PCT No. PCT/FR95/01307 Sec. 371 Date Jun. 3, 1997 Sec. 102(e) Date Jun. 3, 1997 PCT Filed Oct. 6, 1995 PCT Pub. No. WO97/14004 PCT Pub. Date Apr. 17, 1997The invention relates especially to a refrigerating device comprising a pressure-resistant container (1) furnished with an adsorbent material (2), which device furthermore comprises an adjustably set valve (7) whose passage communicates, on the one hand, with the inside of the container and, on the other hand, with the outside, and means (5, 6) for bringing said container temporarily into communication with a pressurized source (10, 11) of gas which can be adsorbed by said adsorbent material. Use in refrigerated clothing or portable refrigerators.
Patent DE-69516447-T2 (DE)
Inventor: JANSSEN WILHELMUS HENRICUS J
IPC: A01G5/02
Filed: 1995-01-12
Granted: 2000-10-12
Abstract: The invention relates to a device for sorting and bundling flowers. The device has been provided with a frame and with a conveyor belt, which runs in a substantially horizontal plane during operation and to which supporting means are coupled so as to support the flowers. Said supporting means are capable of reciprocating movement in said substantially horizontal plane with respect to the conveyor belt in order to deliver the flowers to a second conveyor belt provided near a bundling station. A plurality of fork-shaped means are coupled to said second conveyor belt so as to be pivotable about horizontal pivot axes. Weights are coupled to said pivotal fork-shaped means in such a manner that said weights attempt to keep said fork-shaped means in a horizontal position.
Patent DE-69525647-T2 (DE)
Inventor: PASQUALINI ROBERTO
IPC: A61K47/48
Filed: 1995-11-13
Granted: 2002-10-17
Abstract: PCT No. PCT/FR95/01489 Sec. 371 Date May 14, 1997 Sec. 102(e) Date May 14, 1997 PCT Filed Nov. 13, 1995 PCT Pub. No. WO96/14881 PCT Pub. Date May 23, 1996The invention relates to radio-pharmaceutical compositions that include an inclusion complex of a cyclodextrin and a radio-halogenated fatty acid. These complexes include a cyclodextrin such as  beta -cyclodextrin,  gamma -cyclodextrin and their derivatives, and a radio-halogenated fatty acid, in particular a fatty acid labelled with radioactive iodine such as 16-iodo 3-methyl hexadecanoic acid suitable for the examination of the myocardium by scintigraphy. The cyclodextrin allows the fatty acid to dissolve in aqueous solution without any addition of human blood albumin, while further improving the biodistribution of the fatty acid and its stability to heat.
Patent DE-69529339-T2 (DE)
Inventor: JONES PETER
IPC: C25C3/14
Filed: 1995-05-11
Granted: 2003-09-04
Abstract: An actuator assembly comprises a piston within an actuating cylinder, and a valve for controlling the flow of actuating fluid to the first side of the piston. When the valve is actuated the flow of fluid to the first side of the piston is stopped and the pressure of the actuating fluid on the piston is sufficient to maintain the piston in a predetermined position along the stroke path. Also disclosed is a method of actuating the crust breaker of a smelter pot using the apparatus described. Fluid leakage through the piston rod sealing assembly is reduced; the volume of compressed air used by the smelter is reduced; and the working life of the actuator is improved.
Patent DE-69602633-T2 (DE)
Inventor: ASSEFPOUR-DEZFULLY MASSOUD
IPC: B22D11/06
Filed: 1996-02-08
Granted: 2000-03-16
Abstract: A steel strip (12) is continuously cast from a pool (30) of molten metal that is supported on one or more chilled casting surfaces (22A). The casting surfaces (22A) are moved to produce a solidified strip (12) moving away from the casting pool (30) along a transit path (10). The formation of scale on the solidified strip (12) as it passes through the transit path (10) is controlled by confining the solidified strip within an enclosure (37) from which oxygen is extracted by oxidation of the strip and which is sealed to control ingress of oxygen containing atmosphere.
Patent DE-69615015-T2 (DE)
Inventor: ZHABILOV P
IPC: A61K38/00
Filed: 1996-05-01
Granted: 2002-06-27
Abstract: This invention relates to the area of immunology and virology, and specifically relates to compositions obtainable from mammalian thymus cells which are useful as diagnostics, vaccines, and therapeutics for human immunodeficiency virus (HIV) infection and related diseases such as acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). The diagnostic, vaccination, and therapeutic methods, and devices, using these compositions are also disclosed. <IMAGE>
Patent DE-69620821-T2 (DE)
Inventor: VAN HALL MAURICE
IPC: A62B25/00
Filed: 1996-06-07
Granted: 2002-08-14
Abstract: A harness to enable the wearer to carry an article such as breathing apparatus comprises a waist belt (9) carrying a waist plate (1) to which a back plate (21) is secured. The harness includes shoulder straps (20) and a means (41,50) of securing the article to it. The back plate (21) is moveable with respect to the waist plate (1) to facilitate movement of the wearer's body. <IMAGE>
Patent DE-69623063-T2 (DE)
Inventor: BATES IAN
IPC: B60W30/18
Filed: 1996-02-07
Granted: 2003-05-08
Abstract: A control system and method for a semi-automatic mechanical transmission system (10) is provided for sensing rolling start conditions (OS > REF, GR = N, (CLUTCH MANUAL DISENGAGED = TRUE)) and upon sensing such conditions, allowing operator request for a direct shift into an appropriate rolling start gear ratio (GRRS) determined as a function of current and/or expected output shaft speed (GRRS ESIDLE/OS). <IMAGE>
Patent DE-69624914-T2 (DE)
Inventor: GRANDICS PETER
IPC: G01N33/86
Filed: 1996-05-08
Granted: 2003-09-18
Abstract: A method and device is described for direct removal of heparin from whole blood during extracorporeal therapy. In clinical situations where the blood is heparinized to prevent clotting in the extracorporeal circuit containing e.g., a hemodialysis cartridge or a heart-lung machine, it would be desirable to eliminate the systemic heparinization of the patients. The extracorporeal circuit contains a device having antithrombin III immobilized and inserted between the outlet port of the primary extracorporeal device, such as the hemodialysis cartridge or heart-lung machine and the patient. When the heparinized blood comes in contact with the immobilized antithrombin III, heparin is removed and the reperfused blood is substantially free of heparin. The advantage of the system lies in the fact that heparin is removed from the blood rather than neutralized. This helps overcome the adverse reactions and side effects associated with the use of heparin anticoagulation.
Patent DE-69627232-T2 (DE)
Inventor: CRUPPER RANDOLPH SCOTT
IPC: G11B7/125
Filed: 1996-01-18
Granted: 2003-11-20
Abstract: The optical drive system described comprises an optical assembly, a light source, an objective lens disposed in an objective lens subassembly, an actuator assembly which suspends the objective lens subassembly for relative motion thereof with respect to the actuator assembly, first and second servomotors for moving the objective lens subassembly in tracking and focusing directions, respectively, relative to the actuator assembly, a third servomotor for moving the actuator assembly in the tracking direction relative to a medium, first electronic means for controlling the first, second, and third servomotors, a motor with a hub assembly for moving the medium relative to the objective lens subassembly, a photo detector, second electronic means responsive to an output signal of the photo detector for decoding information carried in the light returning from the medium, third electronic means for enabling the light source to emit light at a first intensity level to encode information on the medium and at a second intensity level to read information encoded thereon, data receiving means for accepting data that is storable on the medium, data encoding means being responsive to the data receiving means for representing the data to be stored in a predetemined format, the data encoding means also for directing data to the third electronic means, a magnetic field generator for producing a magnetic field on a portion of the medium and for coacting with the third electronic means and the light source to write and erase information on the medium, a cartridge loading assembly, servo error detecting means coupled to the first electronic means, and a housing structure for positioning components of the optical drive system with respect to one another.The system claimed include means to monitor and use a Quad Sum signal associated with the return light for focus capture.
Patent DE-69628030-T2 (DE)
Inventor: GIRARD FRANCOIS
IPC: A63C9/20
Filed: 1996-11-20
Granted: 2004-04-08
Abstract: The fastening (3) consists of a coupling element (6) which is fixed to the upper surface of the ski (2). It engages with a pin (9) projecting from the sole of the boot (1) in a zone between the tips of the toes and the metatarsal-phalangeal joints. It also incorporates a control member which provides a permanent direct or indirect contact between the tip of the boot sole and the ski when the heel is raised. <??>The control member has a stop (18) which limits the upward flexible movement of the coupling element (6) in relation to the ski. It also has a transverse guide for the coupling element, which is in the form of a metal wire or a spring vane with a hook-shaped end (7) for engaging with the boot sole pin (9) by the action of the fastening control lever (5).
Patent DE-69631417-T2 (DE)
Inventor: HASSARD FRANCIS
IPC: G01N21/33
Filed: 1996-05-10
Granted: 2004-07-01
Abstract: A method of imaging molecules of interest within a biological sample includes shining a UV light onto the sample and detecting the molecular UV absorption. Where the molecules of interest are themselves UV absorbers, the intrinsic absorption of those molecules may be used. If the molecules of interest are not good UV absorbers, UV-aborbing tag molecules may be use. The method may be used in molecular imaging devices of all types, and in DNA sequences. A novel diamond-based detector is disclosed which is suitable for many applications.
Patent DE-69637229-T2 (DE)
Inventor: SHEN WEI-CHIANG
IPC: A61K47/48
Filed: 1996-01-25
Granted: 2008-05-15
Abstract: The invention provides uses of lipid-containing moieties in the manufacture of compounds for delivery of sulfhydryl group-containing compounds into mammalian cells. The sulfhydryl group-containing moieties are suitably peptides, proteins or oligonucleotides which contain or have been modified to contain sulfhdryl group. The lipid-containing moiety is conjugated to the sulfhydryl group-containing moiety via a disulphide linkage. Preferred lipid-containing moieties are described. <IMAGE>
Patent DE-69637510-T2 (DE)
Inventor: MURATA NORIO
IPC: C12N9/04
Filed: 1996-12-27
Granted: 2009-06-10
Abstract: A method for producing temperature-tolerant plants, which comprises transforming a plant with a recombinant vector carrying a gene encoding choline oxidase, as well as temperature-tolerant plants produced by said method or progenies thereof having the same properties.
Patent DE-69702973-T2 (DE)
Inventor: WESTON EDWARD
IPC: B65B3/02
Filed: 1997-03-27
Granted: 2001-02-22
Abstract: A needleless injector drug capsule assembly comprising a container, housing therefor, a piston, and resilient seals to permit filling and sealing thereafter to maintain sterility of the contents.
Patent DE-69708580-T2 (DE)
Inventor: CUBIZOLLES SERGE
IPC: F22B1/28
Filed: 1997-11-13
Granted: 2002-07-04
Abstract: A steam generator consists of a chamber (12) with heating elements (13), fed with water by a pump (11) and equipped with an electrically- controlled valve (15) for expelling steam. It also has a regulator in the form of a temperature or pressure sensor (14) to monitor the amount of water in the chamber and to actuate the pump. The regulator is connected to an electronic system which carries out a succession of measures and operates the pump as a function of the temperature or pressure in the chamber (12). The chamber can comprise a metal container (12a) in thermal contact with the sensor (14), which incorporates an electrical resistance such as a thermistance, and the heating elements are controlled by the electronic system on the basis of data supplied by the sensor.
Patent DE-69721027-T2 (DE)
Inventor: BAUMEISTER PETER
IPC: B01J27/185
Filed: 1997-09-19
Granted: 2003-11-20
Abstract: The present invention relates to a hydrogenation process for the preparation of aromatic amino compounds containing directly on the aryl ring or in a side chain one or more entities that may also undergo hydrogenation, such as carbon multiple bonds, nitrile groups, imino groups or carbonyl groups. The preparation is carried out by catalytic hydrogenation of the corresponding aromatic nitro compounds in the presence of a phosphorus-modified noble metal catalyst. The invention relates also to the use of modified noble metal catalysts for the hydrogenation of aromatic nitro compounds containing carbon multiple bonds and/or substituted by nitrile, imino or carbonyl groups.
Patent DE-69726329-T2 (DE)
Inventor: ADDY TRALANCE O
IPC: A61L2/16
Filed: 1997-04-03
Granted: 2004-11-18
Abstract: A method for hydrogen peroxide vapor sterilization of medical devices and similar instruments having long narrow lumens or diffusion restricted areas includes the step of pretreating the article to be sterilized with a dilute solution of hydrogen peroxide prior to exposure to a vacuum or a vacuum followed by plasma. The method is such that, upon vaporization of the solution caused by the vacuum, the hydrogen peroxide remains in contact with the article for a time sufficient to achieve sterilization.
Patent DE-69726562-T2 (DE)
Inventor: MURRAY STEVE
IPC: B63J99/00
Filed: 1997-04-24
Granted: 2004-09-30
Abstract: A engine kill switch system has a transmitter and receiver which are linked through specific transmitted codes within a frequency. The receiver is mounted directly on the boat and wired to an engine kill switch, maintaining the switch in the closed position as long as a signal is received from all of the activated transmitters. Once the transmitter signal is unintentionally deactivated, the receiver shuts down the engine. A range adjustment allows the separation distance between the transmitter and receiver to be changed, dependent upon the size of the boat and end use. A strobe and audio warning can also be attached to the receiver and activated simultaneously with, or as an alternative to, the deactivation of the engine. Automatic transmitter activation and deactivation can be provided through storage ports tied to the receiver. The transmitter is a battery powered remote device carried by a user. The transmitter has a programmed unique code recognized by the receiver. The system, or individual components, are provided with deactivation codes entered through an input device. The system can also be used as an antitheft device simply by removal of one transmitter, thereby rendering the engine inoperable.
Patent DE-69732492-T2 (DE)
Inventor: BAKER RAYMOND
IPC: C07D413/06
Filed: 1997-11-25
Granted: 2006-03-30
Abstract: The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of major depressive disorder with anxiety without concomitant therapy with other anti-depressant or anti-anxiety agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising the same.
Patent DE-69819356-T2 (DE)
Inventor: OPPENHEIM CHARLES
IPC: A61K9/50
Filed: 1998-11-06
Granted: 2004-07-22
Abstract: The invention disclosed herein includes a vitamin composition encapsulated in a soft or hard shell capsule, said vitamin composition comprising water soluble vitamin particles suspended in a fill liquid, wherein said water soluble vitamin particles are coated with a material that is substantially insoluble in the fill liquid and the shell of the capsule, but soluble in the gastrointestinal tract of a mammal, and the coated water soluble vitamin particles are of a size that are suitable for encapsulating as a suspension in said capsule. The invention also includes a process for manufacturing the same. Vitamin containing capsules according to this invention are discoloration-resistant.
Patent DE-69826303-T2 (DE)
Inventor: CERDA VILAPLANA GUSTAVO
IPC: G11B33/04
Filed: 1998-12-22
Granted: 2005-09-29
Abstract: Disclosed is a case (1) with a lid (1a), a portion of box or bottom (1b) hinged by a central portion of the back (1c), as well as circonferential protuberances bearing onto the external edge of the disc-shaped magnetic recording medium. For nesting-removing the disc central orifice, a device is provided which is comprised of a cylindrical platform (2) having a central formation (2a) which is also cylindrical and on which bears the lower surface of said disc. Around a prismatic-hexagonal protuberance (2b), pins or lugs (3) are concentrically conformed. Said lugs (3) have retention teeths (5) which are separated from the base of the central formation (2a) by a distance (H) which is equivalent to the thickness of the recording medium. In a preferred embodiment, an articulation or hinge seal (7) is configured around the cylindrical platform (2) and is integrally molded as a zone having a reduced wall thickness with a groove (7a) and a bead (7b). <IMAGE>   <IMAGE>
Patent DE-69826464-T2 (DE)
Inventor: RUTKOWSKI F
IPC: D01D5/18
Filed: 1998-05-28
Granted: 2006-02-23
Abstract: A spinner head is used for spinning and processing feedstock material. The spinner head includes spaced tubular heating elements which are covered by annular housing that forms a material processing wall. The annular housing contains radially spaced slots which provide a passage way for the material to be expelled from the spinner head. Each slot contains a flow restricting insert removably insertable therein. The inserts include radially extending grooves which channel the feedstock material as it exits the spinner head. The insert further include latches extending therefrom which secure the inserts in the spinner head upon rotation.
Patent DE-69826644-T2 (DE)
Inventor: KAMM MICHAEL ALBERT
IPC: A61K31/554
Filed: 1998-02-23
Granted: 2005-11-17
Abstract: Nifedipine, optionally in combination with bethanechol, is administered locally to the anus for the treatment of benign anal disorders, in particular anal fissures and haemorrhoids. The agents induce a reduction in the mean and resting pressure, thereby assisting in the healing of anal fissures and haemorrhoids. Optionally, the active agents may be co-administered with a steroid, such as hydrocortisone.
Patent DE-69826721-T2 (DE)
Inventor: ALLISON S
IPC: D06C21/00
Filed: 1998-12-09
Granted: 2005-11-17
Abstract: A heating system for a mechanical compressive shrinkage apparatus in which a continuously flowing liquid heat exchange medium is caused to flow in series through each of the components required to be heated. Heat is input to the flowing medium in accordance with the temperature of one of the components to be heated, preferably the first in the series. Uniformity and constancy of both absolute and relative temperatures of the series-connected components is achieved. A mixture of water and propylene glycol alcohol is an advantageous heat exchange medium for the purpose, which allows operation at lower pressure without the maintenance problems of a system using, for example, oil as the exchange medium.
Patent DE-69827392-T2 (DE)
Inventor: TUCH KLAUS
IPC: A61K45/06
Filed: 1998-07-21
Granted: 2005-10-27
Abstract: The invention relates to the use of proton pump inhibitors as combination therapeutics in the treatment of bacterial diseases which do not affect the gastrointestinal track using antibacterially active compounds.
Patent DE-69827940-T2 (DE)
Inventor: GETMAN P
IPC: C07D309/12
Filed: 1998-03-04
Granted: 2005-06-09
Abstract: An amidoaromatic ring sulfonamide hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed, as are a treatment process that comprises administering a contemplated amidoaromatic ring sulfonamide hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.
Patent DE-69833675-T2 (DE)
Inventor: JORDAN T
IPC: G01N33/579
Filed: 1998-10-02
Granted: 2006-11-16
Abstract: The invention provides methods and compositions for the detection and/or quantification of bacterial endotoxins. In particular, provided herein is an inexpensive and reproducible method for producing an improved amebocyte lysate preparation having reduced Factor G activity. Provided also is an endotoxin-specific amebocyte lysate preparation produced by such a method. In addition, the invention provides methods and compositions for enhancing the sensitivity to endotoxins of amebocyte lysate preparations having reducing Factor G activity. In particular, the sensitivity of such amebocyte lysate preparations to endotoxins can be enhanced by the addition of exogenous (1->3) beta-D-glucan.
Patent DE-69900528-T2 (DE)
Inventor: MONTESSORO EZIO
IPC: C08G2/08
Filed: 1999-05-25
Granted: 2002-07-25
Abstract: A process for the di-ter-peroxide synthesis, wherein the condensation reaction between a tertiary hydroperoxide and a tertiary alcohol is carried out in the presence of an acid catalyst, constituted by a compound having a mono-sulphonated aromatic ring selected from the following formulae: <CHEM> wherein: R is an alkyl group having from 2 to 9 carbon atoms, preferably from 2 to 6; R'and R'' are alkyl groups having a number of from 1 to 9 carbon atoms, preferably from 1 to 6.